Ono Pharma & Phylo AI: Accelerating Drug Discovery

Ono Pharmaceutical Company Limited is partnering with Phylo, Inc. to integrate agentic AI into its drug discovery process. This collaboration brings Phylo's Biomni Lab, an AI platform for biomedical research, to Ono's scientists. Here's the thing: Biomni Lab lets scientists work with AI agents to complete complex research tasks. This includes synthesizing experimental history, analyzing internal data, and designing experiments. What's interesting is that this partnership aims to combine Ono's discovery expertise and historical data with Biomni Lab's AI platform. The bottom line: This collaboration is designed to help scientists move from initial questions to new discoveries much faster.